Reversal Possible With GH3?
10 from "Nutrients to Age Without Senility" by Abram Hoffer, M.D., Ph.D.
and Morton Walker, D.P.M
of prolonged youth and the testimonials of thousands of patients have
carried word of a seemingly miraculous treatment far beyond the borders
of the People's Republic of Rumania. Rumania is the nation of origin
of Ana Aslan, M.D., director of the National Institute of Gerontology
and Geriatrics. Under her supervision, a staff of 1,000 in over 200
Rumanian clinics give treatment to reverse aging using the drug she
has developed called Gerovital H3 (GH3).
by notables including French President Charles De Gaulle, U.S. President
John F. Kennedy, West German Chancellor Konrad Adenauer, Chinese Chairman
Mao Tse Tung and Vietnamese Chairman Ho Chi Minh, were taken to acquire
injections of this youth drug. Actresses Marlene Dietrich, Lillian Gish,
the Gabor sisters, and actors Charlie Chaplin and Kirk Douglas and artist
Salvador Dali have made the journey. They traveled to the Otopeni Clinic
just outside the ancient city of Bucharest, where Dr. Aslan does her
research with GH3. Once discovered by these celebrities, GH3 itself
has become famous and is now used in over twenty countries around the
world. It is available over the counter without prescription in England,
Germany, Italy and Switzerland. However, the U.S. Food and Drug Administration
does not approve of its distribution in any of the other fifty states,
and the American Medical Association concurs with this ruling. [GH3
can be legally imported in the USA, for personal use. You may purchase
here our pharmaceutical grade, original formula with Procaine Hcl].
simply the local anesthetic procaine hydrochloride--used by dentists
and podiatrists - to which has been added buffering agents and other
chemicals to create a hybrid drug (Gerovital H3). The additives have
transformed this local anesthetic into a new medicine that possibly
reverses the aging process (anti-aging). How this came about makes for
an interesting story and reveals a lot more about procaine and its youth
PARHON DISCOVERS PROFESSOR ASLAN
Intensely interested in the problems of aging, Dr. Constantine I. Parhon
founded the Institute of Endocrinology in Bucharest, Rumania, to carry
on his experiments on the functions of the endocrine glands. He published
the first large scale endocrinological work in medical annals fifty
years ago. For forty years, Dr. Parhon continued his experiments searching
constantly for the causes of aging.This
drive of Dr. Parhon's to find the reasons behind aging and perhaps arrive
at a solution to slow down or retard the aging process led him to establish
the Institute of Geriatrics. This Institute was founded at the request
of the Rumanian government in 1951. It had become the center for the
study in the advanced methods for both the treatment of the aged and
retarding the signs of age. One of Dr. Parhon's staff members at the
Institute of Endocrinology was Ana Aslan, M.D. For over twenty years,
this doctor had been a specialist in cardiovascular diseases. She had
been interested in the pharmacodynamical properties of procaine and
the reactions of this drug on the human body. Before coming to the Institute,
Dr. Aslan was a researcher in pharmacology (the science of drugs) at
an experimental clinic in Timisoara, Rumania. It was here that she first
began using procaine in the treatment of asthma and for circulation
her tenure at Timisoara, she uncovered the works of Dr. Gustav Spiess.
He was the first to discover that procaine had many other values besides
its known anesthetic qualities. He wrote reports about his experiments
about the curative powers of this drug which Prof. Aslan read. After
checking this literature, she extended her treatment to include patients
with arthritis and limb embolisms. Another pioneer in this work was
Rene Leriche whose work went further than Dr. Spiess's.
encouraged by these reports, adjusted their methods in her practice.
She also used Leriche's method, who advocated the infiltration of 10
to 25 cc and was able to restore the affected joint or limb of her patients.
These patients, often after two treatments, were able to return
to work and were free of pain. This increased the uses in her practice
from asthmatic patients; she used it as an anti-inflammatory agent for
those suffering from bone and joint diseases.
a dramatic incident to convince Dr. Aslan that she should continue to
concentrate her efforts on developing procaine H3 for anti aging therapy.
She was satisfied that it had many unknown benefits. When injecting
procaine H3 into arthritic joints and other areas of pain, she noticed
her patients' response was most satisfactory. Joints heretofore immobile
or frozen were now mobile and flexible, almost normal. Under Dr. Parhon's
guidance, she continued to experiment at the fine laboratory facilities
at his Institute, working to find the drug's effectiveness on the aged.
Dr. Parhon is convinced that the old age process is treatable exactly
as any other disease. Dr. Aslan, with her research background, advanced
his theory that old age was not only treatable but could also be retarded.
SERIOUS MEDICAL RESEARCH WITH PROCAINE
concur that as the body grows older, definite physiological changes
occur. Many patients exhibit the following group of symptoms:
aging with its complex group of symptoms
Diseases of the aged, loss of memory, energy and vitality
Diseases of the nervous system, diminished hearing abilities, visual acuity
and dulled mental functions Diseases of muscles and joints, rheumatism and
Diseases of skin and allergies, baldness, psoriasis, and the old appearance
of the skin, face and body. Diseases of the cardiovascular system, angina
pectoris and varicose veins
Diseases of the gastrointestinal system, ulcers and stomach disorders.
believes that the body's inherent natural ability to replace cells lost
through disease and age diminishes through the years. Procaine supplements
the body's ability to regenerate the cells. She is convinced that
cell regeneration is responsible for a return of youthfulness to older
people. Her experiments with mice, for the next few years, substantiated
her theory that besides removing the effects of a disease, it had
no side reactions. In mice that developed arthritis, the beneficial
effects and their return to complete mobility was most encouraging.
These successes led her to treat almost 200 patients at the Institute
who exhibited a wide range of dysfunctions. Some patients were suffering
from old age ailments, others from arthritis and degenerative diseases.
she used procaine to treat twenty-five elderly patients, whose range
of ailments was from arthritis to senility; she had apparent successes.
None was happier than this initial group--the blessing to obtain dramatic
relief from diseases that plagued them for years was heartfelt. With
the signs and symptoms of premature aging diminished, Prof. Aslan was
still unsure of which factors worked for her patients. The name of her
treatment--GH3--intrigued her. Could it be that the component parts
of GH3 were needed and used by the body? The fact is that GH3 hydrolizes
in the body releasing these factors.
working with procaine Since 1947 on an experimental basis, using it
for years in the treatment of specific diseases, and making a great
many clinical observations, Dr. Aslan made claims for procaine: when
administered properly and in certain prescribed doses, it would not
only retard the aging process but would relieve chronic ailments, diseases
of old age and premature aging. This remarkable claim for a drug,
known throughout the world as an anesthetic was based on treating 20,000
patients for a period of over fifteen years. Some individual patients
have been treated for as long as ten years. This backlog of patients
provided her with many questions to be resolved. When it was administered,
why were the actions of GH3 so different from another product? Did the
body have the ability to extract the good from the ingredients found
in the product?
Previous page | Top
of this page | Home | Next